enrasentan has been researched along with nitroarginine in 1 studies
Studies (enrasentan) | Trials (enrasentan) | Recent Studies (post-2010) (enrasentan) | Studies (nitroarginine) | Trials (nitroarginine) | Recent Studies (post-2010) (nitroarginine) |
---|---|---|---|---|---|
32 | 2 | 0 | 3,935 | 11 | 175 |
Protein | Taxonomy | enrasentan (IC50) | nitroarginine (IC50) |
---|---|---|---|
Nitric oxide synthase, endothelial | Bos taurus (cattle) | 1.2 | |
Nitric oxide synthase, endothelial | Homo sapiens (human) | 0.38 | |
Nitric oxide synthase, brain | Homo sapiens (human) | 1.265 | |
Nitric oxide synthase, brain | Rattus norvegicus (Norway rat) | 4.12 | |
Nitric oxide synthase, inducible | Mus musculus (house mouse) | 0.5 | |
Nitric oxide synthase, inducible | Homo sapiens (human) | 6.2 | |
Nitric oxide synthase, brain | Mus musculus (house mouse) | 0.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersen, CU; Laursen, BE; López-Valverde, V; Mulvany, MJ; Simonsen, U | 1 |
1 other study(ies) available for enrasentan and nitroarginine
Article | Year |
---|---|
Glibenclamide reveals role for endothelin in hypoxia-induced vasoconstriction in rat intrapulmonary arteries.
Topics: Animals; Anti-Arrhythmia Agents; Carboxylic Acids; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; Endothelium, Vascular; Enzyme Inhibitors; Glyburide; Hypoxia; In Vitro Techniques; Indans; Male; Nitric Oxide Synthase; Nitroarginine; Oligopeptides; Oxyhemoglobins; Peptides, Cyclic; Phenylephrine; Pinacidil; Piperidines; Pulmonary Artery; Rats; Rats, Wistar; Receptors, Endothelin; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2005 |